Chemical Structure : Cilgavimab
货号: PC-38878Not For Human Use, Lab Use Only.
Cilgavimab (AZD1061) is a monoclonal antibody (mAb) against the SARS-CoV-2 spike protein, binds to distinct, nonoverlapping epitopes on the spike protein receptor binding domain to neutralize SARS-CoV-2, used in a combination of Tixagevimab/cilgavimab (AZD7442).
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Cilgavimab (AZD1061) is a monoclonal antibody (mAb) against the SARS-CoV-2 spike protein, binds to distinct, nonoverlapping epitopes on the spike protein receptor binding domain to neutralize SARS-CoV-2, used in a combination of Tixagevimab/cilgavimab (AZD7442).
Isotype: IgG1-kappa.
Anti-[human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein, receptor binding domain (RBD)], human monoclonal antibody.
分子量 | ||
分子式 | ||
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. VanBlargan LA, et al. Nat Med. 2022 Mar;28(3):490-495.
2. Loo YM, et al. Sci Transl Med. 2022 Mar 9;14(635):eabl8124.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright